teclistamab,talquetamab,daratumumab
genmab,janssen
['redirectt-1', 'talquetamab', 'teclistamab', 'mmsm', 'multiple myeloma']
in this video, yael cohen, md, discusses the safety findings from the phase 1/2 redirectt-1 trial of teclistamab-cqyv &amp; talquetamab in relapsed/refractory multiple myeloma. #mmsm #eha2023 | 
Oncology news and insights from leading researchers and cancer centers.